Harmanci et al. found that the majority of atypical meningiomas had NF2 loss and fell into two categories: those with significant chromosomal losses (“CNV-high”) and those with SMARCB1 mutations (“CNV-low”). This evidence concerns the gene NF2 and meningioma.